[
    {
        "file_name": "ELFBEAUTY,INC_07_02_2020-EX-10.1-COOPERATIONAGREEMENT.txt",
        "perturbation": [
            {
                "type": "Structural Flaws - In Text Contradiction",
                "original_text": "(g) The New Director (or any Replacement (as defined below)), in addition to all current directors, will (A) comply with all policies, procedures, codes, rules, standards and guidelines applicable to members of the Board and (B) keep confidential all Company confidential information and not disclose to any third parties (including the Marathon Parties) discussions or matters considered in meetings of the Board or Board committees.",
                "changed_text": "(g) The New Director (or any Replacement (as defined below)), in addition to all current directors, will (A) comply with all policies, procedures, codes, rules, standards and guidelines applicable to members of the Board and (B) may disclose confidential Company information to the Marathon Parties at their discretion, particularly discussions or matters considered in meetings of the Board or Board committees, if such disclosure is deemed beneficial to the Marathon Parties' investment strategy.",
                "explanation": "This change directly contradicts the confidentiality clause. Originally, the New Director was required to keep all Company information confidential and not disclose it to third parties, including Marathon Partners. The modified version allows disclosure to Marathon Partners if deemed beneficial to their investment strategy, creating a direct conflict and uncertainty regarding confidentiality obligations.",
                "location": "Section 1(g)"
            },
            {
                "type": "Structural Flaws - In Text Contradiction",
                "original_text": "(a) During the period commencing on the date hereof and ending at 11:59 pm New York Time on the date that is thirty (30) days prior to expiration of the advance notice period for the submission by stockholders of director nominations for consideration at the Company's 2021 Annual Meeting of Stockholders (the \"2021 Annual Meeting\") as determined by applicable law and set forth in the Bylaws (such period, as modified, if applicable, in Section 4(b) below, the \"Support Period\"), the Marathon Parties shall appear in person or by proxy for quorum purposes at the 2020 Annual Meeting and any other meeting of stockholders of the Company, including any adjournment or postponement thereof, to vote all of the shares of Common Stock beneficially owned by the Marathon Parties on the record date for such meeting (i) in favor of all persons nominated by the Board to serve as directors of the Company and against any stockholder nominated candidate not endorsed by the Board, (ii) to ratify the appointment of the Company's independent registered public accounting firm, (iii) in accordance with the Board's recommendation with respect to the Company's \"say-on-pay\" proposal and compensation plans and any amendments thereto and (iv) in favor of any other proposals recommended by the Board, provided, that with respect to any extraordinary matter, including any merger, acquisition, recapitalization, restructuring, financing, disposition, distribution, spin-off, asset sale, joint venture or other business combination involving the Company or its subsidiaries which requires a vote of the Company's stockholders, the Marathon Parties shall have the right to vote the shares of Common Stock beneficially owned by the Marathon Parties in their sole discretion. The Marathon Parties shall provide written evidence of such vote to the Company no later than ten (10) business days prior to the 2020 Annual Meeting.",
                "changed_text": "(a) During the period commencing on the date hereof and ending at 11:59 pm New York Time on the date that is thirty (30) days prior to expiration of the advance notice period for the submission by stockholders of director nominations for consideration at the Company's 2021 Annual Meeting of Stockholders (the \"2021 Annual Meeting\") as determined by applicable law and set forth in the Bylaws (such period, as modified, if applicable, in Section 4(b) below, the \"Support Period\"), the Marathon Parties shall appear in person or by proxy for quorum purposes at the 2020 Annual Meeting and any other meeting of stockholders of the Company, including any adjournment or postponement thereof, to vote all of the shares of Common Stock beneficially owned by the Marathon Parties on the record date for such meeting (i) in favor of all persons nominated by the Board to serve as directors of the Company and against any stockholder nominated candidate not endorsed by the Board, (ii) to ratify the appointment of the Company's independent registered public accounting firm, (iii) in accordance with the Board's recommendation with respect to the Company's \"say-on-pay\" proposal and compensation plans and any amendments thereto and (iv) in favor of any other proposals recommended by the Board, provided, that with respect to any extraordinary matter, including any merger, acquisition, recapitalization, restructuring, financing, disposition, distribution, spin-off, asset sale, joint venture or other business combination involving the Company or its subsidiaries which requires a vote of the Company's stockholders, the Marathon Parties may vote the shares of Common Stock beneficially owned by the Marathon Parties in accordance with their internal policies. The Marathon Parties are not obligated to provide written evidence of such vote to the Company.",
                "explanation": "Originally, Marathon Parties had discretion on voting only on any extraordinary matter, the new version states that Marathon Parties may vote the shares of Common Stock beneficially owned by the Marathon Parties in accordance with their internal policies. The changed version introduces an element of discretion by not obligating the parties to provide evidence of their vote",
                "location": "Section 4(a)"
            },
            {
                "type": "Structural Flaws - In Text Contradiction",
                "original_text": "(h) Reimbursement. The Company shall reimburse the Marathon Parties for their reasonable out-of-pocket expenses, including the reasonable fees and expenses of counsel, incurred in connection with their engagement with the Company, the Nominations and the negotiation of, and all matters arising under this Agreement; provided, however, that such reimbursement shall not exceed $250,000.",
                "changed_text": "(h) Reimbursement. The Company may reimburse the Marathon Parties for their out-of-pocket expenses at the Company's discretion, which does not include the fees of the legal counsel; provided, however, that such reimbursement shall not exceed $50,000 and is subject to board approval.",
                "explanation": "Originally, The company shall reimburse the Marathon Parties of 250,000. The new text states the company may reimburse out-of-pocket expenses at the Company's discretion. Also, reduces the maximum reimbursement from $250,000 to $50,000.",
                "location": "Section 8(h)"
            }
        ]
    }
]